Elawyers Elawyers
Washington| Change

Boston Heart Diagnostics Corporation v. MD Labs, Inc., 3:18-cv-00006. (2018)

Court: District Court, D. Nevada Number: infdco20180419d78 Visitors: 8
Filed: Apr. 18, 2018
Latest Update: Apr. 18, 2018
Summary: STIPULATION TO DISMISS WITH PREJUDICE ROBERT C. JONES , District Judge . Plaintiff Boston Heart Diagnostics Corporation ("BHDX") and Defendant MD Labs, Inc. ("MD Labs," together with BHDX, the "Parties"), through their counsel, hereby stipulate, subject to the approval of the Court, to the following: 1. The Parties agree and stipulate that the above-captioned action, Boston Heart Diagnostics Corporation v. MD Labs, Inc., No. 3:18-cv-0006, which alleges infringement of U.S. Patent No. 8,4
More

STIPULATION TO DISMISS WITH PREJUDICE

Plaintiff Boston Heart Diagnostics Corporation ("BHDX") and Defendant MD Labs, Inc. ("MD Labs," together with BHDX, the "Parties"), through their counsel, hereby stipulate, subject to the approval of the Court, to the following:

1. The Parties agree and stipulate that the above-captioned action, Boston Heart Diagnostics Corporation v. MD Labs, Inc., No. 3:18-cv-0006, which alleges infringement of U.S. Patent No. 8,455,194 against MD Labs (the "Action"), is hereby dismissed with prejudice.

2. The Parties agree and stipulate that MD Labs has not asserted any counterclaims in the Action and will not be precluded in any future litigation from challenging the infringement, validity, or enforceability of U.S. Patent No. 8,455,194 and, further, that BHDX will not be precluded from asserting any defenses thereto.

3. The Parties further agree and stipulate that each party shall bear its own attorneys' fees and costs incurred in, or in connection with, the Action.

IT IS SO STIPULATED.

IT IS SO ORDERED.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer